Feature Channels: Personalized Medicine

Filters close
Newswise:Video Embedded patch-detects-muscle-movement-through-skin-w-nanomagnets
VIDEO
Released: 27-Jun-2023 6:30 PM EDT
This patch uses nanomagnets to detect muscle movement through the skin
Cell Press

Using nanomagnets composites and conductive yarn, scientists have invented a smart textile that can sense and measure body movements—from muscles flexing to veins pulsing.

   
Released: 26-Jun-2023 4:05 PM EDT
Mayo Clinic uses genomic testing broadly for rare diseases, improves patient care
Mayo Clinic

A Mayo Clinic study published in Journal of Translational Medicine evaluated the use of genomic testing broadly for rare diseases.

Released: 23-Jun-2023 5:05 PM EDT
Nuclear medicine global initiative reports worldwide challenges and opportunities in theranostics education
Society of Nuclear Medicine and Molecular Imaging

Leaders from 12 nuclear medicine organizations around the world have issued a white paper about the challenges and opportunities in theranostics education.

Released: 21-Jun-2023 4:05 PM EDT
Laser therapy is most effective treatment for tinnitus, study finds
Sao Paulo Research Foundation (FAPESP)

Low-level laser therapy and associated photobiomodulation is the most effective of the known treatments for tinnitus, according to a study comparing the main therapies in current use, conducted by Brazilian scientists affiliated with the Optics and Photonics Research Center (CEPOF).

16-Jun-2023 2:10 PM EDT
Brain stimulation may prove helpful to acute stroke patients, pilot study suggests
University of California, Los Angeles (UCLA), Health Sciences

There are few effective treatments for acute stroke, and many patients aren’t eligible for them. An innovative pilot study from UCLA Health found promising results for a new potential treatment: highly targeted electrical stimulation to the affected brain area.

Newswise: NCCN Convenes Policy Summit Assessing Impact of Geography on Cancer Outcomes, Examining Rural and Urban Divide
Released: 15-Jun-2023 2:00 PM EDT
NCCN Convenes Policy Summit Assessing Impact of Geography on Cancer Outcomes, Examining Rural and Urban Divide
National Comprehensive Cancer Network® (NCCN®)

Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—convened a policy summit to examine how geography impacts cancer outcomes.

Released: 13-Jun-2023 7:50 PM EDT
People who preserve ‘immune resilience’ live longer, resist infections
University of Texas Health Science Center at San Antonio

Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress — called “immune resilience” — differs widely among individuals.

Newswise: Bioprinting personalized tissues and organs within the body: A breakthrough in regenerative medicine
Released: 13-Jun-2023 12:45 PM EDT
Bioprinting personalized tissues and organs within the body: A breakthrough in regenerative medicine
Institute of Physics (IOP) Publishing

In situ bioprinting, which involves 3D printing biocompatible structures and tissues directly within the body, has seen steady progress over the past few years.

Released: 8-Jun-2023 1:05 PM EDT
Identifying the cause of heart muscle disease in children is key to effective treatment
American Heart Association (AHA)

Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.

Newswise: Does multimorbidity impact chronic disease treatment?
30-May-2023 1:30 PM EDT
Does multimorbidity impact chronic disease treatment?
PLOS

Treatment efficacy for a broad range of chronic diseases does not differ depending on patients’ comorbidities, according to a new study publishing June 6th in the open access journal PLOS Medicine by David McAllister of the University of Glasgow, UK, and colleagues.

5-Jun-2023 2:55 PM EDT
Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies
University of California, Los Angeles (UCLA), Health Sciences

Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organoids that are designed to mimic the function and architecture of real tumors. The improved process allows researchers to use an advanced imaging method to study and analyze individual organoids in great detail, which can help researchers identify personalized treatments for people with rare or hard-to-treat cancers.

31-May-2023 7:15 PM EDT
Personalizing Prostate Cancer Screening May Improve the Accuracy of Detection
University of California, San Francisco (UCSF)

The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a multi-center study led by UC San Francisco and Stanford University, publishing June 1 in Nature Medicine.

Released: 30-May-2023 6:00 AM EDT
As consultas médicas do futuro na Mayo Clinic poderiam ser impulsionadas pela pesquisa nas ciências “ômicas”
Mayo Clinic

Para vislumbrar o futuro da medicina, conheça o Centro de Medicina Individualizada de última geração da Mayo Clinic. No Centro, médicos, pesquisadores, cientistas de dados, engenheiros de inteligência artificial e especialistas em bioética estão trabalhando em estreita colaboração para investigar os massivos conjuntos de dados “ômicos”.

Released: 30-May-2023 6:00 AM EDT
Las futuras visitas médicas en Mayo Clinic podrían estar potenciadas por la investigación en las “ómicas”
Mayo Clinic

Para vislumbrar el futuro de la medicina, ingrese al Centro de Medicina Personalizada de última generación en Mayo Clinic. Allí, médicos, investigadores, analistas de datos, ingenieros de inteligencia artificial y bioéticos trabajan a la par para investigar los inmensos conjuntos de datos de las ómicas.

Released: 30-May-2023 6:00 AM EDT
زيارات أطباء مايو كلينك إلى المستقبل قد تُجرى بدعم من أبحاث “أوميكس”
Mayo Clinic

لتحصل على لمحة عن مستقبل الطب، ما عليك إلا أن تخطو داخل مركز مايو كلينك المتطور للطب الشخصي. فهناك يعمل الأطباء والباحثون وعلماء البيانات ومهندسو الذكاء الاصطناعي واختصاصيو أخلاقيات علم البيولوجيا جنبًا إلى جنب لفحص مجموعات بيانات "أوميكس" الضخمة. هذا النهج المبتكر هو نتاج مشاركة آلاف المرضى في الدراسات البحثية والتجارب السريرية المرتبطة بأوميكس.

Newswise: New Bladder Cancer Classification Predicts Treatment Response
Released: 24-May-2023 5:05 PM EDT
New Bladder Cancer Classification Predicts Treatment Response
Cedars-Sinai

Investigators from Cedars-Sinai Cancer, working in collaboration with colleagues in Colorado and the Netherlands, have identified a specific type of bladder cancer most likely to resist first-line treatment.

Released: 18-May-2023 8:25 AM EDT
Researchers Target Commonly Mutated or Deleted Gene in Gynecological Cancers
Sbarro Health Research Organization (SHRO)

A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted in various types of human cancer, including gynecological cancers.

Released: 16-May-2023 2:00 PM EDT
May is Melanoma and Skin Cancer Awareness Month. Keep up with the latest news on skin in the Dermatology channel
Newswise

Skin cancer is the most prevalent form of cancer in the United States, with over 5 million cases diagnosed annually. The Centers for Disease Control and Prevention reports that melanoma alone accounts for more than 8,000 deaths each year. Thankfully, skin cancer is highly preventable, making it crucial to prioritize protection. Below are some of the latest headlines in the Dermatology channel.

Newswise: Cedars-Sinai Establece un Centro de Investigación y Educación en Inteligencia Artificial
Released: 10-May-2023 6:30 PM EDT
Cedars-Sinai Establece un Centro de Investigación y Educación en Inteligencia Artificial
Cedars-Sinai

El Departamento de Biomedicina Computacional de Cedars-Sinai recientemente refinó su enfoque en el avance de la inteligencia artificial y el aprendizaje automatizado al establecer el Centro de Investigación y Educación de Inteligencia Artificial.

Newswise: EXI unveils first digital implementations of Exercise is Medicine®
Released: 10-May-2023 3:45 PM EDT
EXI unveils first digital implementations of Exercise is Medicine®
American College of Sports Medicine (ACSM)

EXI – the Software as a Medical Device (SaMD) that delivers personalized physical activity prescription and behavior change support for people with long-term health conditions – has unveiled its first Exercise is Medicine® (EIM) deployment alliances. Freedom Aquatic & Fitness Center (FAFC) – located onsite at George Mason University Science & Technology campus in Manassus, Virginia, with a specialist team that delivers EIM in the community and via health provider referrals – and Logan Health, a Montana healthcare system offering EIM programs through its medical fitness center in Kalispell, Montana, will be the first facilities to deploy Exercise is Medicine® using EXI’s digital platform.

Newswise: Behind the Scenes of a Major Genomic Discovery
7-May-2023 11:00 AM EDT
Behind the Scenes of a Major Genomic Discovery
Mount Sinai Health System

Eimear Kenny, PhD, had just completed undergrad and was working in her first computational genomics job more than 20 years ago when scientists announced the first (nearly) complete sequencing of the human genome—what was considered at the time to be the fundamental blueprint for all humans. The Human Genome Project aimed to map the entire genome in an effort to accelerate the diagnosis and eventual treatment of common and rare diseases.

Newswise: Virginia Tech researchers join together on cancer prevention, diagnosis and treatment
Released: 9-May-2023 2:05 AM EDT
Virginia Tech researchers join together on cancer prevention, diagnosis and treatment
Virginia Tech

May is a month to recognize the importance of cancer research, with both Brain Tumor Awareness Month and National Cancer Research Month taking center stage. Virginia Tech’s Fralin Biomedical Research Institute at VTC is dedicated to advancing our understanding of cancer and developing new ways to treat and prevent it. Teams of investigators are working to uncover the molecular mechanisms that drive cancer growth, migration, and metastasis.

Newswise: Study finds genetic screening of adults would be cost-effective
4-May-2023 11:35 AM EDT
Study finds genetic screening of adults would be cost-effective
Vanderbilt University Medical Center

An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.

Released: 8-May-2023 3:45 PM EDT
UC Irvine scientists develop gene silencing DNA enzyme that can target a single molecule
University of California, Irvine

Researchers from the University of California, Irvine have developed a DNA enzyme – or DNAzyme – that can distinguish between two RNA strands inside a cell and cut the disease-associated strand while leaving the healthy strand intact. This breakthrough “gene silencing” technology could revolutionize the development of DNAzymes for treating cancer, infectious diseases and neurological disorders.

Released: 5-May-2023 10:30 AM EDT
Mayo Clinic Platform expands its distributed data network to partner to globally transform patient care
Mayo Clinic

Mayo Clinic Platform is expanding its distributed data network, Mayo Clinic Platform_Connect, to include Hospital Israelita Albert Einstein in Brazil, Sheba Medical Center in Israel and University Health Network (UHN) in Canada, joining Mercy, Connect’s first member. The first-of-its-kind global alliance establishes a data-sharing network that transcends language barriers and accelerates AI-based solutions by using current data science and years of clinical data to create better patient outcomes around the world.

Released: 4-May-2023 1:40 PM EDT
Leading Physician-Scientist Dr. Bradley A. Maron Appointed Senior Associate Dean for Precision Medicine at UMSOM and Co-Director of new University of Maryland Institute for Health Computing (UM-IHC) at UMB
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Bradley A. Maron, MD, Associate Professor of Medicine at Brigham & Women’s Hospital (BWH) and Harvard Medical School (HMS), and Co-Director of the Pulmonary Vascular Disease Center at the VA Boston Healthcare System, has been appointed Co-Director of the UMB’s new Institute for Health Computing (UM-IHC), Director of Scientific Operations for the UM-IHC at UMSOM, as well as Senior Associate Dean for Precision Medicine at the UMSOM, effective May 1, 2023.

   
Released: 4-May-2023 12:50 PM EDT
Lurie Children’s Hospital First in Illinois to Be Designated as a Rare Disease Center of Excellence by National Organization for Rare Disorders (NORD)
Ann and Robert H. Lurie Children's Hospital of Chicago

Ann & Robert H. Lurie Children’s Hospital of Chicago is the first in Illinois to receive designation as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare diseases. The network is led by the National Organization for Rare Disorders (NORD) and is designed to foster knowledge sharing between rare disease experts across the country to help meet the unmet needs of more than 25 million Americans living with a rare disease.

Released: 4-May-2023 12:00 PM EDT
National Network of NORD Rare Disease Centers of Excellence Expands to 40 U.S. Medical Institutions
National Organization for Rare Disorders (NORD)

Today, the National Organization for Rare Disorders (NORD) announced the addition of nine new Rare Disease Centers of Excellence, bringing the total number of medical centers in this network to 40 on the day of the 40th anniversary of NORD's founding.

Released: 4-May-2023 11:25 AM EDT
Cleveland Clinic Rare Disease Center Recognized as a National Center of Excellence by National Organization for Rare Disorders
Cleveland Clinic

Cleveland Clinic has been designated a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The new Cleveland Clinic Center for Rare Diseases is one of 40 U.S. academic medical centers selected to join the first-of-it-kind national network dedicated to diagnosing, treating and researching all rare diseases.

Newswise: Association of American Physicians Taps Cedars-Sinai Leader as President-Elect
Released: 3-May-2023 1:40 PM EDT
Association of American Physicians Taps Cedars-Sinai Leader as President-Elect
Cedars-Sinai

Physician-scientist Paul Noble, MD, chair of the Department of Medicine at Cedars-Sinai, was named president-elect of the Association of American Physicians (AAP) at the group's annual meeting in Chicago on April 22.

Newswise: Nationally Recognized Orthopedic Surgeons Partnering with Hackensack Meridian to Launch New, State-of-the-Art Practice – Orthopedic Specialists of New Jersey
Released: 3-May-2023 12:30 PM EDT
Nationally Recognized Orthopedic Surgeons Partnering with Hackensack Meridian to Launch New, State-of-the-Art Practice – Orthopedic Specialists of New Jersey
Hackensack Meridian Health

Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, announced that nationally recognized orthopedic surgeons are partnering with the network to launch Orthopedic Specialists of New Jersey.

Newswise: Study: Artificial Intelligence May Predict Heart Attacks
Released: 1-May-2023 5:30 PM EDT
Study: Artificial Intelligence May Predict Heart Attacks
Cedars-Sinai

What if your physician could predict if—or when—you might experience a heart attack, cardiac arrest or another heart-related problem?

   
Released: 27-Apr-2023 6:20 PM EDT
How can we fight blood cancer more effectively?
ETH Zürich

Multiple myeloma is a rare blood cancer caused by the uncontrolled multiplication of abnormal plasma cells. These plasma cells are a special type of white blood cells that play an important role in the immune system by producing essential antibodies in the bone marrow and lymph nodes.

25-Apr-2023 10:05 AM EDT
UCLA researchers identify lethal molecular alterations after present-day therapies fail patients with metastatic melanoma
University of California, Los Angeles (UCLA), Health Sciences

In a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the organs of recently deceased patients to understand how metastatic cutaneous melanoma spreads in those who had initially benefited from precision therapies.

Released: 26-Apr-2023 10:05 AM EDT
New wearable tech promising for personalized rehab devices
Cornell University

Researchers at Cornell University have developed a knitted wearable tool to treat hand edema – swelling caused by excess fluid accumulation, from injury or disease – that can be personalized and used in the comfort of one’s own home.

Newswise:Video Embedded live-event-for-april-21-sleeping-pill-reduces-levels-of-alzheimer-s-proteins
VIDEO
Released: 21-Apr-2023 3:10 PM EDT
TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer’s proteins
Newswise

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

       
Newswise: Healing after Muscle Injury Depends on Biological Sex
12-Apr-2023 2:45 PM EDT
Healing after Muscle Injury Depends on Biological Sex
American Physiological Society (APS)

The time period in which muscles heal after injury may depend on biological sex, and applying personalized treatment may help optimize recovery, according to a new study.

Newswise: Engineering the Next Generation of Cell and Gene Therapies
Released: 20-Apr-2023 4:20 PM EDT
Engineering the Next Generation of Cell and Gene Therapies
Cedars-Sinai

Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments.

Newswise:Video Embedded new-breast-cancer-standards-emphasize-individualized-patient-care
VIDEO
Released: 19-Apr-2023 10:00 AM EDT
New Breast Cancer Standards Emphasize Individualized Patient Care
American College of Surgeons (ACS)

To address the unique needs of today’s patients with breast disease and breast cancer, the American College of Surgeons (ACS) National Accreditation Program for Breast Centers (NAPBC) has released new standards for accredited centers that place patients at the center of the framework.

Released: 19-Apr-2023 7:05 AM EDT
Black and socioeconomically disadvantaged patients with vascular disease have worse symptoms, bypass outcomes
Michigan Medicine - University of Michigan

Black and socioeconomically disadvantaged patients with peripheral arterial disease have more severe symptoms before bypass surgery – and are at greater risk for amputation and other complications after the procedure, a new study shows. Researchers say health care providers need to recognize the vulnerability of certain subgroups to adverse outcomes and be on alert for early signs and symptoms of PAD to manage patients accordingly.

Newswise: Cedars-Sinai Cancer 2023: Transforming Research, Patient Care
Released: 18-Apr-2023 4:20 PM EDT
Cedars-Sinai Cancer 2023: Transforming Research, Patient Care
Cedars-Sinai

Cedars-Sinai Cancer’s commitment to convergent science—the deep melding of computational, physical engineering and biological sciences—is evident throughout its 2023 Annual Report.

Released: 18-Apr-2023 6:00 AM EDT
¿La prescripción de opioides repercute en la función cognitiva de los adultos mayores?
Mayo Clinic

El uso de la prescripción de opioides puede tener un efecto negativo en la función cognitiva de los adultos mayores de acuerdo con un estudio reciente de Mayo Clinic publicado en la revista de la Sociedad Estadounidense de Geriatría.

Released: 17-Apr-2023 2:30 PM EDT
Ketamine May Be More Effective in Reducing Postoperative Pain in Patients With a Higher TSP
American Society of Regional Anesthesia and Pain Medicine (ASRA)

A study has found that ketamine may be more helpful in preventing postoperative pain among a subset of patients with a higher tendency toward central sensitization as measured by TSP (temporal summation of pain).

Newswise: AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
13-Apr-2023 3:35 PM EDT
AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
University of Texas MD Anderson Cancer Center

A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.

Newswise: Stay CALM when the heart skips a beat
Released: 17-Apr-2023 1:05 AM EDT
Stay CALM when the heart skips a beat
Kyoto University

A new CALM mutation causes lethal arrhythmia in humans. Using cardiomyocytes -- or heart muscle cells -- from human iPS cell and recombinant calmodulin proteins, the group studied catecholaminergic polymorphic ventricular tachycardia -- or CPVT, a rare and life-threatening genetic condition. The team was able to reproduce severe arrhythmia in patient-derived iPS cell models of exercise-induced CPVT with calmodulin mutations.

Released: 13-Apr-2023 6:00 AM EDT
Massoterapia com inteligência artificial? Conheça o robô em estudo pela Mayo Clinic
Mayo Clinic

Receber uma massagem de um robô pode parecer algo saído de uma história de ficção científica, mas essa pode ser uma realidade em um futuro não muito distante.

   
Released: 13-Apr-2023 6:00 AM EDT
¿Masoterapia con inteligencia artificial? Conozca al robot que se está estudiando en Mayo Clinic
Mayo Clinic

Recibir un masaje de parte de un robot puede parecer algo salido de un cuento de ciencia ficción, pero podría ser una realidad en un futuro no tan lejano.

   


close
1.38747